Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy

Nutrition Reviews

Volumn 61, Issue 10, 2003, Pages 346-351

  Cotter, Alice ^a   Cashman, Kevin D ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Genistein; HRT; Phytoestrogens; Postmenopausal bone loss

Indexed keywords

ESTRADIOL; GENISTEIN; PHYTOESTROGEN;

BONE DENSITY; BONE MINERAL; BREAST TENDERNESS; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; VAGINA BLEEDING;

ANTICARCINOGENIC AGENTS; BONE DENSITY; FEMALE; GENISTEIN; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; TIME FACTORS;

EID: 0141885250     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2003.oct.346-351     Document Type: Review

References (22)

1. Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab. 1995;80:2709-2714.
2. Gallagher JC. Role of estrogens in the management of postmenopausal bone loss. Rheum Dis Clin North Am. 2001;27:143-162.
3. Taylor M. Alternatives to conventional hormone replacement therapy. Compr Ther. 1997;23:514-532.
4. Agnusdei D, Gennari C, Bufalino L. Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone. Osteoporos Int. 1995;5:462-466.
5. Cassidy A. Physiological effects of phyto-oestrogens in relation to cancer and other human health risks. Proc Nutr Soc. 1996;55:399-417.
6. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002;17:1904-1912.
7. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 1998;139:4252-4263.
8. Ishimi Y, Miyaura C, Ohmura M, et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology. 1999;140:1893-1900.
9. Arjmandi BH. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll Nutr. 2001;20:398S-402S.
10. Arjmandi BH, Smith BJ. Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem. 2002;13:130-137.
11. Valtueña S, Cashman K, Robins SP, Cassidy A, Kardinaal A, Branca F. Investigating the role of natural phytoestrogens on bone health in postmenopausal women. Br J Nutr. 2003;89:S87-S99.
12. Dalais FS, Rice GE, Wahlquist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric. 1998;1:124-129.
13. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998;68:1375S-1379S.
14. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr. 2000;72:844-852.
15. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med. 2001;46:221-226.
16. Chiechi LM, Secreto G, D'Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas. 2002;42:295-300.
17. Greendale GA, FitzGerald G, Huang MH, et al. Dietary soy isoflavone and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol. 2002;155:746-754.
18. Cashman K, Flynn A. Optimal nutrition: calcium, magnesium and phosphorus. Proc Nutr Soc. 1999;58:477-487.
19. Bloedon LT, Jeffcoat AR, Lopaczynski W, et al. Safety and pharmacokinetics of purified soy isoflavones: single dose administration to postmenopausal women. Am J Clin Nutr. 2002;76:1126-1137.
20. Kiely M, Faughnan M, Wähälä K, Brants H, Mulligan A. Phyto-oestrogen levels in foods: the design and construction of the VENUS database. Br J Nutr. 2003;89:S19-S23.
21. Davis SR, Murkies AL, Wilcox G. Phytoestrogens in clinical practice. Int Med. 1998;1:27-34.
22. Van Erp-Baart MAJ, Brants HAM, Kiely M, et al. Isoflavone intake in 4 different European countries: the VENUS approach. Br J Nutr. 2003;89:S25-S30.